Feasibility of ion-exchange solid phase extraction inductively coupled plasma mass spectrometry for discrimination between inorganic As(III) and As(V) in phosphate-rich in vitro bioaccessible fractions of Ayurvedic formulations

Dániel Kovács, Ádám Veszely, Dániel Enesei, M. Óvári, G. Záray, V. Mihucz

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Determination of potentially toxic elements in the μg/kg–mg/kg concentration range in some Ayurvedic formulations was performed after microwave-assisted acid digestion and inductively coupled plasma mass spectrometry. Arsenic and Hg concentration in the mineral formulations reached about 10% and 0.6% by weight, respectively. Arsenic bioaccessibility was not influenced by pepsin and pancreatin containing model suspensions of pH = 1.2 and 6.8 (with 0.05 M K2HPO4), respectively. The bioaccessible As fraction of the mineral formulations was about 10–20%, even if the estimated As intake from these products exceeded the 3.0 μg/BW kg/day benchmark dose limit with an increased incidence of 0.5% for lung cancer (BMDL05) caused by inorganic As by about 25 times. Ion-exchange solid phase extraction procedure was applied to discriminate between iAs species in either the initial bioaccessible fractions obtained by incubation in simulated duodenal juice or by spiking them with 75 and 150 μg/L arsenate ions [iAsV]. The complex sample/extractant matrix caused a 60–70% recovery for iAs(V) and a breakthrough of about 20%. Suppression of phosphate ions in the extractant improved iAs(V) recovery by about 10%. Arsenic breakthrough was not observable at the 75 μg/L iAs(V) spike level. Similar results were obtained on a homeopathic product confirming the interference of phosphate on As speciation in bioaccessible fractions of complementary and alternative medicines (CAMs). Conversion rate of iAs(III)/iAs(V) in Ayurvedic products with large As content could be estimated. This approach is more informative than extrapolation of results by X-ray based techniques on solid state of CAMs.

Original languageEnglish
Pages (from-to)1-9
Number of pages9
JournalSpectrochimica Acta - Part B Atomic Spectroscopy
Volume153
DOIs
Publication statusPublished - Mar 1 2019

Fingerprint

Inductively coupled plasma mass spectrometry
inductively coupled plasma mass spectrometry
Arsenic
arsenic
discrimination
solid phases
Ion exchange
phosphates
Phosphates
medicine
formulations
Medicine
Minerals
products
pepsin
recovery
minerals
Pancreatin
Ions
juices

Keywords

  • Alternative medicine
  • Bioaccessibility
  • Cinnabar
  • Homeopathy
  • Realgar

ASJC Scopus subject areas

  • Analytical Chemistry
  • Atomic and Molecular Physics, and Optics
  • Instrumentation
  • Spectroscopy

Cite this

@article{5ece587058bd43ffbef36d59ef0aa6da,
title = "Feasibility of ion-exchange solid phase extraction inductively coupled plasma mass spectrometry for discrimination between inorganic As(III) and As(V) in phosphate-rich in vitro bioaccessible fractions of Ayurvedic formulations",
abstract = "Determination of potentially toxic elements in the μg/kg–mg/kg concentration range in some Ayurvedic formulations was performed after microwave-assisted acid digestion and inductively coupled plasma mass spectrometry. Arsenic and Hg concentration in the mineral formulations reached about 10{\%} and 0.6{\%} by weight, respectively. Arsenic bioaccessibility was not influenced by pepsin and pancreatin containing model suspensions of pH = 1.2 and 6.8 (with 0.05 M K2HPO4), respectively. The bioaccessible As fraction of the mineral formulations was about 10–20{\%}, even if the estimated As intake from these products exceeded the 3.0 μg/BW kg/day benchmark dose limit with an increased incidence of 0.5{\%} for lung cancer (BMDL05) caused by inorganic As by about 25 times. Ion-exchange solid phase extraction procedure was applied to discriminate between iAs species in either the initial bioaccessible fractions obtained by incubation in simulated duodenal juice or by spiking them with 75 and 150 μg/L arsenate ions [iAsV]. The complex sample/extractant matrix caused a 60–70{\%} recovery for iAs(V) and a breakthrough of about 20{\%}. Suppression of phosphate ions in the extractant improved iAs(V) recovery by about 10{\%}. Arsenic breakthrough was not observable at the 75 μg/L iAs(V) spike level. Similar results were obtained on a homeopathic product confirming the interference of phosphate on As speciation in bioaccessible fractions of complementary and alternative medicines (CAMs). Conversion rate of iAs(III)/iAs(V) in Ayurvedic products with large As content could be estimated. This approach is more informative than extrapolation of results by X-ray based techniques on solid state of CAMs.",
keywords = "Alternative medicine, Bioaccessibility, Cinnabar, Homeopathy, Realgar",
author = "D{\'a}niel Kov{\'a}cs and {\'A}d{\'a}m Veszely and D{\'a}niel Enesei and M. {\'O}v{\'a}ri and G. Z{\'a}ray and V. Mihucz",
year = "2019",
month = "3",
day = "1",
doi = "10.1016/j.sab.2019.01.002",
language = "English",
volume = "153",
pages = "1--9",
journal = "Spectrochimica Acta, Part B: Atomic Spectroscopy",
issn = "0584-8547",
publisher = "Elsevier",

}

TY - JOUR

T1 - Feasibility of ion-exchange solid phase extraction inductively coupled plasma mass spectrometry for discrimination between inorganic As(III) and As(V) in phosphate-rich in vitro bioaccessible fractions of Ayurvedic formulations

AU - Kovács, Dániel

AU - Veszely, Ádám

AU - Enesei, Dániel

AU - Óvári, M.

AU - Záray, G.

AU - Mihucz, V.

PY - 2019/3/1

Y1 - 2019/3/1

N2 - Determination of potentially toxic elements in the μg/kg–mg/kg concentration range in some Ayurvedic formulations was performed after microwave-assisted acid digestion and inductively coupled plasma mass spectrometry. Arsenic and Hg concentration in the mineral formulations reached about 10% and 0.6% by weight, respectively. Arsenic bioaccessibility was not influenced by pepsin and pancreatin containing model suspensions of pH = 1.2 and 6.8 (with 0.05 M K2HPO4), respectively. The bioaccessible As fraction of the mineral formulations was about 10–20%, even if the estimated As intake from these products exceeded the 3.0 μg/BW kg/day benchmark dose limit with an increased incidence of 0.5% for lung cancer (BMDL05) caused by inorganic As by about 25 times. Ion-exchange solid phase extraction procedure was applied to discriminate between iAs species in either the initial bioaccessible fractions obtained by incubation in simulated duodenal juice or by spiking them with 75 and 150 μg/L arsenate ions [iAsV]. The complex sample/extractant matrix caused a 60–70% recovery for iAs(V) and a breakthrough of about 20%. Suppression of phosphate ions in the extractant improved iAs(V) recovery by about 10%. Arsenic breakthrough was not observable at the 75 μg/L iAs(V) spike level. Similar results were obtained on a homeopathic product confirming the interference of phosphate on As speciation in bioaccessible fractions of complementary and alternative medicines (CAMs). Conversion rate of iAs(III)/iAs(V) in Ayurvedic products with large As content could be estimated. This approach is more informative than extrapolation of results by X-ray based techniques on solid state of CAMs.

AB - Determination of potentially toxic elements in the μg/kg–mg/kg concentration range in some Ayurvedic formulations was performed after microwave-assisted acid digestion and inductively coupled plasma mass spectrometry. Arsenic and Hg concentration in the mineral formulations reached about 10% and 0.6% by weight, respectively. Arsenic bioaccessibility was not influenced by pepsin and pancreatin containing model suspensions of pH = 1.2 and 6.8 (with 0.05 M K2HPO4), respectively. The bioaccessible As fraction of the mineral formulations was about 10–20%, even if the estimated As intake from these products exceeded the 3.0 μg/BW kg/day benchmark dose limit with an increased incidence of 0.5% for lung cancer (BMDL05) caused by inorganic As by about 25 times. Ion-exchange solid phase extraction procedure was applied to discriminate between iAs species in either the initial bioaccessible fractions obtained by incubation in simulated duodenal juice or by spiking them with 75 and 150 μg/L arsenate ions [iAsV]. The complex sample/extractant matrix caused a 60–70% recovery for iAs(V) and a breakthrough of about 20%. Suppression of phosphate ions in the extractant improved iAs(V) recovery by about 10%. Arsenic breakthrough was not observable at the 75 μg/L iAs(V) spike level. Similar results were obtained on a homeopathic product confirming the interference of phosphate on As speciation in bioaccessible fractions of complementary and alternative medicines (CAMs). Conversion rate of iAs(III)/iAs(V) in Ayurvedic products with large As content could be estimated. This approach is more informative than extrapolation of results by X-ray based techniques on solid state of CAMs.

KW - Alternative medicine

KW - Bioaccessibility

KW - Cinnabar

KW - Homeopathy

KW - Realgar

UR - http://www.scopus.com/inward/record.url?scp=85060116546&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060116546&partnerID=8YFLogxK

U2 - 10.1016/j.sab.2019.01.002

DO - 10.1016/j.sab.2019.01.002

M3 - Article

VL - 153

SP - 1

EP - 9

JO - Spectrochimica Acta, Part B: Atomic Spectroscopy

JF - Spectrochimica Acta, Part B: Atomic Spectroscopy

SN - 0584-8547

ER -